RENOVARO INC. - COMMON STOCK

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

02 окт 2023 09:25:00 Источник Nasdaq GlobeNewswire

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

29 сен 2023 09:15:00 Источник Nasdaq GlobeNewswire

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

30 авг 2023 09:15:00 Источник Nasdaq GlobeNewswire

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

21 авг 2023 09:15:00 Источник Nasdaq GlobeNewswire

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

09 авг 2023 09:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

23 июн 2023 17:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

08 июн 2023 08:45:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences’ CEO Letter to Shareholders

03 апр 2023 09:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

29 мар 2023 09:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

13 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

23 фев 2023 16:04:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

30 ноя 2022 17:20:12 Источник Nasdaq GlobeNewswire

Enochian BioSciences Forges Ahead With Focused Approach, Promising Future

24 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

21 окт 2022 17:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

17 окт 2022 08:30:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor

25 июл 2022 10:15:16 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data

01 июл 2022 17:00:00 Источник Nasdaq GlobeNewswire

Scientific Leaders Agree on Promise of Enochian BioSciences

31 май 2022 08:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company

25 май 2022 16:20:30 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience

20 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire